Search results

Selected filters:

Life Sciences
News

Article type

Topic

Sector

Regions

Year

124 results found for your search

Sort options
05 February 2019

USPTO rules on patent term adjustment set to change following CAFC decision

The Federal Circuit’s precedential judgment in Supernus Pharmaceuticals v Iancu is good news for rights holders – especially those in life sciences

04 February 2019

New names added to <em>IAM</em>'s list of Asia-Pac's market-leading IP operations

The Asia IP Elite identifies companies and institutions in the region that have world class IP functions. Here we introduce the 18  latest additions and explain why they have made the cut

01 February 2019

Getting to the heart of the life sciences patent debate

SPC disputes, second medical use issues, pharma UPC strategies, CRISPR and much more from IAM’s third annual  pharma and biotech IP conference, which took place in London earlier this week

31 January 2019

Pressure piles on US pharma and biotech IP owners

America's life sciences innovators face accusations of using patents to build monopolies and overcharge for vital medicines. If they do not tell their side of the story and fast, they risk losing vital protections on which they rely   

30 January 2019

Winners of the inaugural Global IP Awards named at gala dinner in London

Law and attorney firms from around the world recognised for their outstanding work in litigation, prosecution and transactions during 2018

23 January 2019

Kokes hails "fantastic first year" as NantWorks CIPO

In exclusive interview with IAM, after confirming as a speaker for IPBC Global 2019, the former BlackBerry IP chief talks in-depth about life sciences and high tech convergence - and the many patent opportunities that creates 

23 January 2019

Welcome to the future of patents

New IAM research reports identify the key trends shaping the global IP market – and tell you how to respond

22 January 2019

Bridgestone's TomTom acquisition shows that data is the new gold rush

The $1 billion deal emphasises that for IP professionals a detailed understanding of data-related issues is set to become essential

21 January 2019

It's time to prepare for the IP monetisation revolution

The rise of disruptive new technology means that everything you thought you knew about making money from IP is set to change

18 January 2019

The clock is ticking as US government shutdown threatens to cause major pharma patent disruption

Services at the FDA could “grind to a halt” in a matter weeks if the budget deadlock between President Trump and Democrats continues. Major disruption at the USPTO and in the courts may also be on the cards.

16 January 2019

New collaboration between leading IP brands set to boost global patent transactions

IAM Market teams up with Richardson Oliver Insights to deliver new tranche of assets to its IP buying, selling, licensing and tech transfer platform being offered by top brokers

16 January 2019

Five things you must know about CRISPR

An insider’s guide to how it has revolutionised the life sciences patent landscape - and will continue to do so

15 January 2019

Indian IP jurisprudence is the real winner in the Monsanto cotton technology case

Supreme Court decision does not bring any clarity to the technical issues at stake, but it does establish clear rules for how judges should handle complex patent suits

21 December 2018

Life sciences round-up - UK Supreme Court rules in landmark case, patent linkage shelved in China, big CAFC decision and much more

A summary of the major IP news from the biotechnology, pharmaceutical and medical technology sectors in November and the first-half of December

12 December 2018

Supreme Court of India set to rule in crucial plant innovation dispute

The decision in Monsanto’s appeal against the revocation of a key patent right could have profound implications on the ability to protect agro-biotech inventions in India